三维矢量磁共振弹性成像评估组织机械异质性以评价肝病进展
研究通过三维矢量磁共振弹性成像(MRE)像素直方图分析肝剪切硬度和损耗模量的异质性,在25只大鼠和179名参与者中评估其与MASLD炎症、纤维化的关系;结果显示异质性随纤维化和炎症加重而升高,减重术后1年剪切硬度变异系数下降。
要点
- 剪切硬度变异系数从健康者0.12升至4期纤维化0.30,损耗模量变异系数从健康者0.31升至3级炎症0.51。
- 减重术后1年剪切硬度变异系数从0.16(IQR 0.14-0.18)降至0.14(IQR 0.12-0.16)(P = .009)。
- 肝硬化大鼠损耗模量变异系数与门静脉压力及纤维化面积比变异正相关(ρ = 0.52,P = .008;ρ = 0.55,P = .005)。
核心结论
- MRE评估的组织机械异质性与MASLD进展正相关,显示其作为肝病严重程度和治疗干预生物标志物的潜力。
研究设计与样本
- 临床研究分析两项前瞻性研究(2015年9月至2022年11月)共179名参与者的数据,包括部分接受减重手术者在治疗前后行MRE检查; preclinical研究纳入25只大鼠每月检查。
诊断标准与关键数值
- 剪切硬度变异系数在健康参与者为0.12、4期纤维化参与者为0.30;损耗模量变异系数在健康参与者为0.31、3级炎症参与者为0.51。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health challenge, with evidence indicating that hepatic inflammation and fibrosis are heterogeneous processes. Purpose To measure liver mechanical property heterogeneity using MR elastography (MRE) and evaluate its potential as a biomarker for tissue inflammation and fibrosis in patients with MASLD. Materials and Methods Mechanical tissue heterogeneity in MASLD was assessed at three-dimensional vector MRE pixel-wise histogram analysis of shear stiffness and loss modulus in preclinical and clinical studies. The preclinical study involved 25 rats that were examined monthly, whereas the clinical study analyzed data from 179 participants across two prospective studies (September 2015 to November 2022), including some who underwent bariatric surgery at pretreatment and posttreatment MRE examinations. Mean and coefficient of variation (CV) of shear stiffness and loss modulus were calculated for each examination. Nonparametric tests and Spearman correlation coefficient were used to compare MRE-derived tissue mechanics with biopsy-confirmed fibrosis and inflammation and assess correlations with portal pressure and histopathologic hepatic fibrosis. Results The preclinical study showed that, in cirrhotic livers, CV of loss modulus positively correlated with portal pressure and fibrosis area ratio variation (ρ = 0.52 [P = .008] and 0.55 [P = .005], respectively). The clinical study showed that, in 10 healthy volunteers (median age, 36.5 years; IQR, 34.0-38.8 years; five females) and 169 participants with MASLD (median age, 50.1 years; IQR, 41.0-58.2 years; 118 females), CV of sheer stiffness (from 0.12 to 0.30 in healthy participants to participants with stage 4 fibrosis) and loss modulus (from 0.31 to 0.51 in healthy participants to participants with grade 3 inflammation) increased with increasing severity of fibrosis and inflammation, respectively. In 36 participants who underwent bariatric surgery, the CV of sheer stiffness decreased at the 1-year follow-up, from 0.16 (IQR, 0.14-0.18) to 0.14 (IQR, 0.12-0.16) (P = .009). Conclusion Tissue mechanical heterogeneity assessed at MRE positively correlated with progression of MASLD, demonstrating potential as a biomarker for liver disease severity and therapeutic intervention. ClinicalTrials.gov Identifier: NCT02565446 Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Moura Cunha in this issue.
引用
- Wu H, Zhu Z, Li J, et al. Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression. Radiology. 2025. PMID: 40167439. doi:10.1148/radiol.242349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。